---
title: "Management With Fear of Cancer in Women Undergoing Colposcopy: Randomized Controlled Study"
nct_id: NCT06263062
overall_status: UNKNOWN
phase: NA
sponsor: Alanya Alaaddin Keykubat University
study_type: INTERVENTIONAL
primary_condition: Cancer Fear
countries: Turkey (Türkiye)
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT06263062.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT06263062"
ct_last_update_post_date: 2024-02-16
last_seen_at: "2026-05-12T06:14:16.785Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Management With Fear of Cancer in Women Undergoing Colposcopy: Randomized Controlled Study

**Official Title:** Impact of the Awareness-Based Initiation Program on Cancer Fear and Awareness Level in Women Undergoing Colposcopy: Randomized Controlled Study

**NCT ID:** [NCT06263062](https://clinicaltrials.gov/study/NCT06263062)

## Key Facts

- **Status:** UNKNOWN
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 60
- **Lead Sponsor:** Alanya Alaaddin Keykubat University
- **Conditions:** Cancer Fear, Cervical Cancer
- **Start Date:** 2021-01-07
- **Completion Date:** 2024-06-15
- **CT.gov Last Update:** 2024-02-16

## Brief Summary

Cervical cancer is the fourth most common cancer in women worldwide. Due to advances in early diagnosis and treatment, the number of survivors of cancer has increased over the past 50 years. Therefore, the current standard of care for the detection of cervical neoplasm, a Papanicolaou smear and then a colposcopic biopsy, requires a high degree of diagnostic accuracy. In particular, the fear of developing cancer after cancer screening tests is becoming an increasingly significant problem, with an impact on psychosocial health in individuals. For people who are afraid of cancer, meditation and awareness training can make it easier for emotions to self-regulate in times of distress and pain. This study aim to conducted to determine the impact of the Awareness-Based Initiation Program on cancer fear and level of awareness in women undergoing colonoscopy.

## Eligibility

- **Minimum age:** 18 Years
- **Maximum age:** 70 Years
- **Sex:** FEMALE
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* Colposcopy procedure due to HSIL, LSIL, ASC-H or HPV on cervical cytology
* Volunteering to participate in the 6-session Mindfulness-Based Coping Programme Knowing what a colposcopy procedure means,

Exclusion Criteria:

* interference with verbal communication,
* being diagnosed with major depressive disorder or psychiatric disorder,
* having participated in MBSR training or meditating before
* Lack of skills to use smart phones and computers
* learning biopsy results during the programme
```

## Arms

- **Experimental group** (EXPERIMENTAL) — routine care after a colopscopy procedure "Mindfulness-Based Coping Programme" in addition to routine care Prepared in accordance with the MBSR programme. Applied online with Zoom programme Teams in groups of 6 people 6 sessions in 2 weeks
- **Control group** (NO_INTERVENTION) — routine care after a colopscopy procedure Routine care will be provided by the nurse training handbook created by the researcher

## Interventions

- **Awareness-Based Coping with Fear of Cancer Programme** (BEHAVIORAL) — The content of the Training Program was created by researchers based on MBSR, in line with high-level research results and international guides.Then, the necessary arrangements were made bytaking the opinions of 10 experts ( faculty members of the department of obstetrics and gynaecology nursing, psychiatry specialist, faculty members of the gynaecology oncology department, oncology clinic psychologist, obstetrics and gynaecology clinic charge nurse). Content concluded in accordance with the comments received.

## Primary Outcomes

- **The Cancer Worry Scale** _(time frame: This scale will be administered twice: pre-intervention and immediately after the intervention)_ — The Cancer Worry Scale was developed by Custers et al. (2014) and consists of 8 items. In the Likert scale, the responses are numbered from 0 to 4. In the scale, 0 is expressed as "almost never", while 4 is expressed as "almost always". In the scoring of the scale, the lowest score is 0 and the highest score is 32. Cronbach's alpha value was determined as 0.87.

## Secondary Outcomes

- **Philadelphia Mindfulness Scale** _(time frame: This scale will be administered twice: pre-intervention and immediately after the intervention)_

## Locations (1)

- Alanya Alaaddin Keykubat University, Alanya, Turkey (Türkiye) — _RECRUITING_

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.alanya alaaddin keykubat university|alanya||turkey (türkiye)` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT06263062.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT06263062*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*